Who makes supernus?
Supernus Pharmaceuticals, Inc.
SUPERNUS’ STORY Over the last 30 years, we have built an extensive expertise in product development. Initially, we were a stand-alone development organization, then a U.S. subsidiary of Shire plc and, in late 2005, we became Supernus Pharmaceuticals, Inc.
What does supernus do?
What are Supernus’ focus areas? Supernus is a specialty pharmaceuticals company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company’s lead products, Oxtellar XR® and Trokendi XR®, are for the treatment of epilepsy.
What drugs does supernus make?
We have a diverse portfolio of products that treat psychiatric and neurological conditions including epilepsy, Parkinson’s disease, migraine, and more.
- https://www.qelbree.com. Qelbree. Visit Qelbree website »
- https://www.oxtellarxr.com. Oxtellar XR. Visit Oxtellar XR website »
- https://www.trokendixr.com. Trokendi XR.
Where is supernus Pharmaceuticals located?
Rockville, MD
Supernus Pharmaceuticals is headquartered in Rockville, MD and has 1 office location across 1 country.
How do you pronounce supernus?
Supernus Pharmaceuticals Pronunciation. Su·per·nus Phar·ma·ceu·ti·cals.
Is Viloxazine a stimulant?
Both are stimulant medications approved recently by the FDA for use in both adult and pediatric patients. Most of these medications target the norepinephrine levels in the brain and improve the neurotransmitters’ connectivity and function.
How many employees does supernus?
363 employees
How many Employees does Supernus Pharmaceuticals have? Supernus Pharmaceuticals has 363 employees.
Why was viloxazine taken off the market?
Although it appeared to be an effective antidepressant (Aberg-Wistedt, 1982), it was withdrawn in 1984 because of its idiosyncratic side-effects, notably the Guillain-Barre syndrome.
What arthritis drug was taken off the market?
April 7, 2005 — The popular arthritis drug Bextra will be pulled from the U.S. market under a decision issued by the FDA Thursday.
Is Qelbree an antidepressant?
Rettew noted that viloxazine was marketed as an antidepressant in other countries before being marketed as a treatment for ADHD in the United States. “[Qelbree] therefore has many of the same warnings [as antidepressants], such as the potential for increased suicidal thoughts and activation of mania.
What kind of diseases does Supernus Pharmaceuticals treat?
We are a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Over the last 30 years, we have built an extensive expertise in product development.
Can a Supernus product be sold outside the US?
We also seek strategic collaborations with other pharmaceutical companies to license our products outside the United States.
Who is the CEO of Supernus pharmaceutical company?
ERIN AGUSTINUS: Whether marketing, whether finance, all the way up to our CEO, Jack. JONATHAN RUBIN: There’s a lot of energy and there’s passion for the work.
What does Supernus do for research and development?
Research and development are key parts of what we do at Supernus. Explore the science behind our work and our pipeline of promising product candidates. Our products fall into a number of therapeutic categories and are designed to provide important health benefits to patients living with CNS diseases.
